• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国慢性丙型肝炎病毒感染患者中病毒和宿主基因型的分布及其临床相关性

Distribution and clinical correlates of viral and host genotypes in Chinese patients with chronic hepatitis C virus infection.

作者信息

Rao Huiying, Wei Lai, Lopez-Talavera Juan Carlos, Shang Jia, Chen Hong, Li Jun, Xie Qing, Gao Zhiliang, Wang Lei, Wei Jia, Jiang Jianning, Sun Yongtao, Yang Ruifeng, Li Hong, Zhang Haiying, Gong Zuojiong, Zhang Lunli, Zhao Longfeng, Dou Xiaoguang, Niu Junqi, You Hong, Chen Zhi, Ning Qin, Gong Guozhong, Wu Shuhuan, Ji Wei, Mao Qing, Tang Hong, Li Shuchen, Wei Shaofeng, Sun Jian, Jiang Jiaji, Lu Lungen, Jia Jidong, Zhuang Hui

机构信息

Peking University People's Hospital, Peking University Hepatology Institute, Beijing Key Laboratory for Hepatitis C and Immunotherapy for Liver Disease, Beijing, China.

出版信息

J Gastroenterol Hepatol. 2014 Mar;29(3):545-53. doi: 10.1111/jgh.12398.

DOI:10.1111/jgh.12398
PMID:24090188
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4272577/
Abstract

BACKGROUND AND AIM

Chronic hepatitis C virus (HCV) infection is relatively frequent in China. This study investigated the clinical, demographic, and viral and host genetic characteristics that may influence disease manifestations and clinical management.

METHODS

In this cross-sectional observational study, treatment-naïve Han ethnic adults with recently confirmed chronic HCV infection were enrolled at 28 hospitals across China. HCV genotype and host interleukin 28B (IL28B) genotypes were determined and compared with patient demographic parameters and medical status.

RESULTS

Among the 997 HCV-positive patients analyzed, 56.8% were infected with HCV genotype 1b, followed in prevalence by genotypes 2, 3, and 6, with substantial regional variation. Overall, 84.1% of patients were IL28B genotype CC (rs12979860), with little regional variation. Cirrhosis was reported in 10.1% of patients and was significantly associated with hepatitis B virus coinfection, low HCV viral load, low serum alanine aminotransferase, high serum aspartate aminotransferase, diabetes, and high pickled food consumption. Medical procedures were common transmission risk factors; however, lifestyle-associated risk factors, including intravenous drug abuse and tattoos or piercings, were more common in patients with HCV genotype 3 or 6.

CONCLUSIONS

Most HCV-infected Han Chinese patients were IL28B genotype CC (rs12979860). HCV genotypes varied by geographic region, and disease characteristics differed according to HCV genotype. Relatively frequent detection of advanced liver disease may reflect limitations on access to antiviral therapy, and suggests that greater awareness of factors that influence HCV-associated disease may help avoid clinical complications and improve patient outcomes.

摘要

背景与目的

慢性丙型肝炎病毒(HCV)感染在中国较为常见。本研究调查了可能影响疾病表现和临床管理的临床、人口统计学、病毒及宿主基因特征。

方法

在这项横断面观察性研究中,来自中国28家医院的初治汉族成年慢性HCV感染患者入组。确定HCV基因型和宿主白细胞介素28B(IL28B)基因型,并与患者人口统计学参数和医疗状况进行比较。

结果

在分析的997例HCV阳性患者中,56.8%感染HCV 1b基因型,其次是2、3和6基因型,存在显著的地区差异。总体而言,84.1%的患者为IL28B基因型CC(rs12979860),地区差异较小。10.1%的患者报告有肝硬化,且与乙型肝炎病毒合并感染、低HCV病毒载量、低血清丙氨酸氨基转移酶、高血清天冬氨酸氨基转移酶、糖尿病和高腌制食品摄入量显著相关。医疗操作是常见的传播危险因素;然而,与生活方式相关的危险因素,包括静脉注射毒品和纹身或穿孔,在HCV 3或6基因型患者中更为常见。

结论

大多数感染HCV的汉族患者为IL28B基因型CC(rs12979860)。HCV基因型因地理区域而异,疾病特征也因HCV基因型而异。晚期肝病相对频繁的检出可能反映了抗病毒治疗可及性的限制,并表明提高对影响HCV相关疾病因素的认识可能有助于避免临床并发症并改善患者预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebba/4272577/ea57e9afade6/jgh0029-0545-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebba/4272577/3c15e300db10/jgh0029-0545-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebba/4272577/34ae740e42c2/jgh0029-0545-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebba/4272577/c3839ce7da2e/jgh0029-0545-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebba/4272577/ea57e9afade6/jgh0029-0545-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebba/4272577/3c15e300db10/jgh0029-0545-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebba/4272577/34ae740e42c2/jgh0029-0545-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebba/4272577/c3839ce7da2e/jgh0029-0545-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebba/4272577/ea57e9afade6/jgh0029-0545-f4.jpg

相似文献

1
Distribution and clinical correlates of viral and host genotypes in Chinese patients with chronic hepatitis C virus infection.中国慢性丙型肝炎病毒感染患者中病毒和宿主基因型的分布及其临床相关性
J Gastroenterol Hepatol. 2014 Mar;29(3):545-53. doi: 10.1111/jgh.12398.
2
Prevalence of IL-28B and ITPA genotypes in Chinese Han population infected persistently with hepatitis C virus genotype 6 or HCV-1.中国汉族丙型肝炎病毒基因型 6 或 HCV-1 持续感染者中 IL-28B 和 ITPA 基因型的流行情况。
J Med Virol. 2013 Jul;85(7):1163-9. doi: 10.1002/jmv.23561.
3
Distribution of IL28B rs12979860 and rs8099917 Genotypes in Patients with Chronic Hepatitis C Virus Infection in Tianjin, China.中国天津慢性丙型肝炎病毒感染患者中IL28B基因rs12979860和rs8099917基因型的分布情况
Clin Lab. 2018 Apr 1;64(4):543-550. doi: 10.7754/Clin.Lab.2017.171036.
4
Interleukin 28B.rs12979860 genotype does not affect hepatitis C viral load in Egyptians with genotype 4 chronic infection.白细胞介素28B基因rs12979860的基因型不影响4型慢性感染的埃及患者的丙型肝炎病毒载量。
Arch Virol. 2015 Nov;160(11):2833-7. doi: 10.1007/s00705-015-2555-3. Epub 2015 Aug 18.
5
Role of interleukin 28B-related gene polymorphisms in chronic hepatitis C and the response to antiviral therapy in Koreans.白细胞介素 28B 相关基因多态性在韩国慢性丙型肝炎患者中的作用及其对抗病毒治疗的反应。
J Clin Gastroenterol. 2013 Aug;47(7):644-50. doi: 10.1097/MCG.0b013e3182896abf.
6
IL28B genetic variations are associated with treatment response of patients with chronic hepatitis C in a Chinese Han population.IL28B基因变异与中国汉族人群慢性丙型肝炎患者的治疗反应相关。
J Dig Dis. 2015 Feb;16(2):90-7. doi: 10.1111/1751-2980.12202.
7
Hepatitis B virus infection in Chinese patients with hepatitis C virus infection: prevalence, clinical characteristics, viral interactions and host genotypes: a nationwide cross-sectional study.中国丙型肝炎病毒感染者中的乙型肝炎病毒感染:流行率、临床特征、病毒相互作用和宿主基因型:一项全国性横断面研究。
BMJ Open. 2016 Oct 12;6(10):e012016. doi: 10.1136/bmjopen-2016-012016.
8
Evaluation of the relationship between IL28B, IL10RB and IL28RA single-nucleotide polymorphisms and susceptibility to hepatitis C virus in Chinese Han population.中国汉族人群中IL28B、IL10RB和IL28RA单核苷酸多态性与丙型肝炎病毒易感性之间关系的评估。
Infect Genet Evol. 2014 Jan;21:8-14. doi: 10.1016/j.meegid.2013.10.009. Epub 2013 Oct 19.
9
IL28B gene polymorphism rs12979860, but not rs8099917, contributes to the occurrence of chronic HCV infection in Uruguayan patients.IL28B 基因多态性 rs12979860 而非 rs8099917 与乌拉圭患者慢性 HCV 感染的发生有关。
Virol J. 2018 Mar 2;15(1):40. doi: 10.1186/s12985-018-0946-2.
10
Prevalence and clinical implications of IL28B genotypes in Taiwanese patients with chronic hepatitis C.台湾慢性丙型肝炎患者中IL28B基因分型的患病率及临床意义
J Formos Med Assoc. 2016 Nov;115(11):953-960. doi: 10.1016/j.jfma.2016.07.013. Epub 2016 Oct 15.

引用本文的文献

1
Epidemiological trends of hepatitis C incidence and death in Mainland China between 2004 and 2018 and its predictions to 2030.2004年至2018年中国大陆丙型肝炎发病率和死亡率的流行病学趋势及其至2030年的预测。
BMC Infect Dis. 2025 Apr 8;25(1):483. doi: 10.1186/s12879-025-10881-y.
2
Is it time for China to prioritize pan-genotypic regimens for treating patients with hepatitis C?中国是时候将泛基因型治疗方案作为治疗丙型肝炎患者的优先选择了吗?
Cost Eff Resour Alloc. 2024 Feb 6;22(1):11. doi: 10.1186/s12962-024-00519-2.
3
Alfosbuvir plus Daclatasvir for Treatment of Chronic Hepatitis C Virus Infection in China.

本文引用的文献

1
IL28B genetic variants and gender are associated with spontaneous clearance of hepatitis C virus infection.IL28B 基因变异和性别与丙型肝炎病毒感染的自发清除有关。
J Viral Hepat. 2012 Mar;19(3):173-81. doi: 10.1111/j.1365-2893.2011.01497.x. Epub 2011 Aug 4.
2
Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b-infected null responders.聚乙二醇干扰素α联合利巴韦林治疗慢性丙型肝炎的疗效及安全性
Hepatology. 2012 Mar;55(3):742-8. doi: 10.1002/hep.24724. Epub 2012 Jan 30.
3
Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews.
在中国,使用阿舒瑞韦联合达卡他韦治疗慢性丙型肝炎病毒感染
Infect Dis Ther. 2023 Nov;12(11):2595-2609. doi: 10.1007/s40121-023-00872-4. Epub 2023 Oct 19.
4
The burden of hepatitis C virus in the world, China, India, and the United States from 1990 to 2019.1990 年至 2019 年全球、中国、印度和美国丙型肝炎病毒负担。
Front Public Health. 2023 Mar 2;11:1041201. doi: 10.3389/fpubh.2023.1041201. eCollection 2023.
5
The Transmission Route and Selection Pressure in HCV Subtype 3a and 3b Chinese Infections: Evolutionary Kinetics and Selective Force Analysis.丙型肝炎病毒 3a 型和 3b 型中国感染者的传播途径和选择压力:进化动力学和选择力分析。
Viruses. 2022 Jul 11;14(7):1514. doi: 10.3390/v14071514.
6
CpG Island Methylation of Suppressor of Cytokine Signaling-1 Gene Induced by HCV Is Associated With HCV-Related Hepatocellular Carcinoma.丙型肝炎病毒诱导的细胞因子信号传导抑制因子-1基因的CpG岛甲基化与丙型肝炎病毒相关肝细胞癌有关。
Front Microbiol. 2022 Jun 6;13:679593. doi: 10.3389/fmicb.2022.679593. eCollection 2022.
7
Distribution and changes in hepatitis C virus genotype in China from 2010 to 2020.2010年至2020年中国丙型肝炎病毒基因型的分布及变化
World J Clin Cases. 2022 May 16;10(14):4480-4493. doi: 10.12998/wjcc.v10.i14.4480.
8
Cost-Effectiveness of Elbasvir/Grazoprevir for the Treatment of Chronic Hepatitis C: A Systematic Review.Elbasvir/Grazoprevir 治疗慢性丙型肝炎的成本效益:系统评价。
Front Public Health. 2022 May 13;10:836986. doi: 10.3389/fpubh.2022.836986. eCollection 2022.
9
Geographic Distribution of HCV Genotypes and Efficacy of Direct-Acting Antivirals in Chronic HCV-Infected Patients in North and Northeast China: A Real-World Multicenter Study.中国北方和东北地区丙型肝炎病毒基因型的地理分布及直接作用抗病毒药物在慢性丙型肝炎病毒感染患者中的疗效:一项真实世界多中心研究。
Can J Gastroenterol Hepatol. 2022 Apr 29;2022:7395506. doi: 10.1155/2022/7395506. eCollection 2022.
10
Cost-Effectiveness Analysis of Pan-Genotypic Sofosbuvir-Based Regimens for Treatment of Chronic Hepatitis C Genotype 1 Infection in China.泛基因型索磷布韦方案治疗中国慢性丙型肝炎病毒 1 型感染的成本效果分析。
Front Public Health. 2021 Dec 9;9:779215. doi: 10.3389/fpubh.2021.779215. eCollection 2021.
全球注射吸毒人群乙型肝炎和丙型肝炎的流行病学:系统评价结果。
Lancet. 2011 Aug 13;378(9791):571-83. doi: 10.1016/S0140-6736(11)61097-0. Epub 2011 Jul 27.
4
Telaprevir for previously untreated chronic hepatitis C virus infection.替拉瑞韦治疗初治慢性丙型肝炎病毒感染。
N Engl J Med. 2011 Jun 23;364(25):2405-16. doi: 10.1056/NEJMoa1012912.
5
A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt.亚洲、澳大利亚和埃及丙型肝炎病毒流行病学的系统评价。
Liver Int. 2011 Jul;31 Suppl 2:61-80. doi: 10.1111/j.1478-3231.2011.02540.x.
6
IL28B SNP rs12979860 is a critical predictor for on-treatment and sustained virologic response in patients with hepatitis C virus genotype-1 infection.IL28B SNP rs12979860 是丙型肝炎病毒基因型 1 感染患者治疗中及持续病毒学应答的关键预测因子。
PLoS One. 2011 Mar 30;6(3):e18322. doi: 10.1371/journal.pone.0018322.
7
Boceprevir for untreated chronic HCV genotype 1 infection.博赛泼维用于治疗未经治疗的慢性 HCV 基因 1 型感染。
N Engl J Med. 2011 Mar 31;364(13):1195-206. doi: 10.1056/NEJMoa1010494.
8
IL28B genetic variations are associated with high sustained virological response (SVR) of interferon-α plus ribavirin therapy in Taiwanese chronic HCV infection.IL28B 基因变异与台湾地区慢性 HCV 感染患者接受干扰素-α联合利巴韦林治疗的高持续病毒学应答(SVR)相关。
Genes Immun. 2011 Jun;12(4):300-9. doi: 10.1038/gene.2011.1. Epub 2011 Feb 24.
9
HCV subtype characterization among injection drug users: implication for a crucial role of Zhenjiang in HCV transmission in China.在注射吸毒者中 HCV 亚型的特征:镇江在中国 HCV 传播中发挥关键作用的启示。
PLoS One. 2011 Feb 3;6(2):e16817. doi: 10.1371/journal.pone.0016817.
10
Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: long-term predictors from a community-based cohort study.丙型肝炎病毒血清标志物与随后发生肝细胞癌的风险:基于社区队列研究的长期预测指标。
J Clin Oncol. 2010 Oct 20;28(30):4587-93. doi: 10.1200/JCO.2010.29.1500. Epub 2010 Sep 20.